CNRGH
Letouze E. et al.
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.
Nat Commun. (2017) Nov. 8(1):1315.
doi: 10.1038/s41467-017-01358-x
Machiela MJ. et al.
Genetic variants related to longer telomere length are associated with increased risk of Renal Cell Carcinoma.
Europ. Urol. (2017) Nov. 72 (5): 747-754
doi: 10.1016/j.eururo.2017.07.015
Manes G. et al.
A novel duplication of PRMD13 causes North Carolina macular dystrophy: overexpression of PRDM13 orthologue in drosophila eye reproduces the human phenotype.
Hum Mol Genet. (2017) Nov. 26(22):4367-4374.
doi: 10.1093/hmg/ddx322
Tronik-Le Roux D. et al.
Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.
Mol Oncol. (2017) Nov. 11(11):1561-1578.
doi: 10.1002/1878-0261
Abath Neto O. et al.
Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
Neuromuscul Disord. (2017) Nov. 27(11):975-985.
doi: 10.1016/j.nmd.2017.05.016
Charmet R. et al.
Association of impaired renal function with venous thrombosis: A genetic risk score approach.
Thromb Res. (2017) Oct. 158:102-107.
doi: 10.1016/j.thromres.2017.08.015
Malfatti E. et al.
Recessive myopalladin mutations cause congenital cap myopathy with unusual rods.
Neuromus. Dis. (2017) Oct. 27: S185-S185.
doi: 10.1016/j.nmd.2017.06.331
Nelson I. et al.
Novel recessive splice site mutation in POPDC1 (BVES) is associated with first-degree atrioventricular block and muscular dystrophy.
Neuromus. Dis. (2017) Oct. 27: S139-S140.
doi: 10.1016/j.nmd.2017.06.172
Troudet R. et al.
RNA signature and prediction to treatment response in first episode schizophrenia.
European Neuropsychopharm. (2017) Oct. 27: S597-S597.
doi: 10.1016/S0924-977X(17)31139-2
Ivanova ELet al.
Homozygous truncating variants in TBC1D23 cause Pontocerebellar Hypoplasia and alter cortical development.
Am J Hum Genet. (2017) Sep. 101(3):428-440.
doi: 10.1016/j.ajhg.2017.07.010